Insider Transactions in Q1 2025 at Adma Biologics, Inc. (ADMA)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2025
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
21,000
-0.51%
|
$378,000
$18.92 P/Share
|
|
Mar 19
2025
|
Adam S Grossman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.72%
|
$75,000
$5.4 P/Share
|
|
Mar 07
2025
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
3,935
-0.77%
|
$66,895
$17.02 P/Share
|
|
Mar 07
2025
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
29,513
-1.41%
|
$501,721
$17.02 P/Share
|
|
Mar 06
2025
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
8,881
-1.7%
|
$142,096
$16.91 P/Share
|
|
Mar 06
2025
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
56,438
-2.62%
|
$903,008
$16.91 P/Share
|
|
Feb 26
2025
|
Brad L. Tade CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,280
-2.02%
|
$79,200
$15.78 P/Share
|
|
Feb 26
2025
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
54,867
-2.48%
|
$823,005
$15.78 P/Share
|
|
Feb 25
2025
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
1,855
-0.35%
|
$27,825
$15.44 P/Share
|
|
Feb 25
2025
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,018
-0.81%
|
$270,270
$15.44 P/Share
|
|
Feb 19
2025
|
Alison Cecily Finger |
BUY
Grant, award, or other acquisition
|
Direct |
10,889
+23.77%
|
-
|
|
Feb 19
2025
|
Jerrold B Grossman |
BUY
Grant, award, or other acquisition
|
Direct |
10,889
+2.23%
|
-
|
|
Feb 19
2025
|
Steve Elms |
BUY
Grant, award, or other acquisition
|
Direct |
10,889
+11.09%
|
-
|
|
Feb 19
2025
|
Lawrence P. Guiheen |
BUY
Grant, award, or other acquisition
|
Direct |
10,889
+6.2%
|
-
|
|
Feb 19
2025
|
Eduardo Rene Salas |
BUY
Grant, award, or other acquisition
|
Direct |
10,889
+50.0%
|
-
|
|
Feb 19
2025
|
Young Kwon |
SELL
Grant, award, or other acquisition
|
Direct |
10,889
-4.14%
|
-
|
|
Feb 19
2025
|
Adam S Grossman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
252,022
+10.17%
|
-
|
|
Feb 19
2025
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
BUY
Grant, award, or other acquisition
|
Direct |
77,784
+12.93%
|
-
|
|
Feb 19
2025
|
Brad L. Tade CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
62,227
+19.21%
|
-
|
|
Jan 30
2025
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
3,355
-0.75%
|
$53,680
$16.1 P/Share
|
|
Jan 30
2025
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.1%
|
$50,000
$10.8 P/Share
|